Androgen Deprivation Therapy in Patients Treated with External Beam Radiotherapy for High-risk Prostate Cancer in the PSA Era
β Scribed by A.D. Vassil; E.S. Murphy; C.G. Robinson; C.A. Reddy; N. Chehade; J.P. Ciezki
- Publisher
- Elsevier Science
- Year
- 2009
- Tongue
- English
- Weight
- 41 KB
- Volume
- 75
- Category
- Article
- ISSN
- 0360-3016
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## BACKGROUND In men with prostate cancer, pretreatment prostateβspecific antigen (PSA) velocity (PSAV) has been demonstrated as a predictor of biochemical and survival outcomes in patients undergoing radical prostatectomy (RP). The utility of pretreatment PSAV in predicting outcomes a
## Abstract ## BACKGROUND To the authors' knowledge, consensus is lacking regarding the relative longβterm efficacy of radical prostatectomy (RP) versus conventionalβdose external beam radiation therapy (RT) in the treatment of patients with clinically localized prostate carcinoma. ## METHODS A